norcantharidin has been researched along with Invasiveness, Neoplasm in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, Y; Gao, Y; Guo, Q; Hua, B; Jiang, S; Li, J; Li, W; Liu, R; Zheng, H | 1 |
| Bae, Y; Huang, X; Jiang, Y; Lee, EY; Li, Y; Lin, HP; Reichel, D; Wang, Z; Xiao, Y; Yang, C | 1 |
| Chien, MH; Chiou, HL; Hsieh, MJ; Hsieh, YH; Yang, SF; Yeh, CB | 1 |
| Cai, J; Chen, X; Chen, Z; Ji, Q; Li, Q; Liu, X; Qiu, Y; Sun, J; Zhang, L; Zhu, H | 1 |
| Chen, CQ; Fan, YZ; Fu, JY; Zhao, ZM | 2 |
6 other study(ies) available for norcantharidin and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Humans; Interleukin-6; Janus Kinase 2; Liver Neoplasms; Neoplasm Invasiveness; STAT3 Transcription Factor; Tumor Cells, Cultured; Twist-Related Protein 1 | 2017 |
In vivo β-catenin attenuation by the integrin α5-targeting nano-delivery strategy suppresses triple negative breast cancer stemness and metastasis.
Topics: Animals; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Drug Delivery Systems; Humans; Integrin alpha5; Mice, Nude; Nanoconjugates; Neoplasm Invasiveness; Neoplastic Stem Cells; Oligopeptides; Triple Negative Breast Neoplasms; Wnt Signaling Pathway | 2019 |
Antimetastatic effects of norcantharidin on hepatocellular carcinoma by transcriptional inhibition of MMP-9 through modulation of NF-kB activity.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Butadienes; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Survival; Hepatocytes; Humans; Liver Neoplasms; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B; Nitriles; Phosphatidylinositol 3-Kinases; Plasminogen Activator Inhibitor 1; Proto-Oncogene Proteins c-akt; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1; Transcription, Genetic; Urokinase-Type Plasminogen Activator; Wound Healing | 2012 |
Norcantharidin inhibits tumor angiogenesis via blocking VEGFR2/MEK/ERK signaling pathways.
Topics: Angiogenesis Inhibitors; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Cyclooxygenase 2; Human Umbilical Vein Endothelial Cells; Humans; Male; MAP Kinase Signaling System; Mice; Mice, SCID; Neoplasm Invasiveness; Neovascularization, Pathologic; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2013 |
[The in vitro effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells and its mechanism].
Topics: Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Gallbladder Neoplasms; Humans; Ki-67 Antigen; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Proliferating Cell Nuclear Antigen; Time Factors; Tissue Inhibitor of Metalloproteinase-2 | 2004 |
Effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Collagen; Drug Combinations; Gallbladder Neoplasms; Humans; In Vitro Techniques; Ki-67 Antigen; Laminin; Matrix Metalloproteinase 2; Medicine, Chinese Traditional; Neoplasm Invasiveness; Proliferating Cell Nuclear Antigen; Proteoglycans; Tissue Inhibitor of Metalloproteinase-2 | 2005 |